Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Syphacia Obvelata Antigens Alter the Foxp3/Rorɣt Expression Balance in Isolated Peripheral Blood Mononuclear Cells of Ibd Patients Publisher Pubmed



A Amin ABBAS ; N Taghipour NILOOFAR ; M Rostaminejad MOHAMMAD ; Fa Avanaki Foroogh ALBORZI ; R Jafarshad REYHANEH ; Sj Seyyedtabaei Seyyed JAVAD ; N Mosaffa NARIMAN
Authors

Source: Scientific Reports Published:2025


Abstract

Inflammatory Bowel Disease (IBD) arises from disrupted interactions among intestinal microbiota, epithelial cells, and the immune system, which are influenced by genetic and environmental factors. A critical factor in IBD pathogenesis is the balance between FOXP3+ regulatory T cells (Tregs) and RORγt+ Th17 cells; a decreased Treg/Th17 ratio can lead to inflammation. Syphacia obvelata may help modulate immune responses by promoting Th2 responses and enhancing Treg populations, potentially impacting FOXP3 and RORγt expression and aiding IBD management. In this study, peripheral Blood Mononuclear Cells (PBMCs) from 6 IBD patients were treated with S. obvelata antigens (ES-Ag, S-Ag, and ES/S-Ag) for 24 h. Optimal concentrations and time points were determined via the MTT assay. Total RNA was extracted, cDNA was synthesized, and RT-qPCR was performed using FOXP3 and RORγt primers. The gene expression fold changes and FOXP3/RORγt ratios were compared to the control group. Results showed that FOXP3 expression was increased significantly after treatment with all S. obvelata antigens, including ES-Ag, S-Ag, and ES/S-Ag, whereas the expression of RORγt decreased significantly in just two groups, including ES-Ag and ES/S-Ag. Eventually, the FOXP3/RORγt gene expression fold change ratio was increased significantly after 24 h of exposure to S. obvelata antigens. Our study indicates that the ES-Ag, S-Ag, and ES/S-Ag of S. obvelata, along with their combination, can increase the FOXP3/RORɣt ratio in PBMCs from patients with IBD, suggesting anti-inflammatory effects. This finding offers hope that these antigens could be an eye-opener for developing future strategies for IBD treatment. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Protective Effect of Tslp and Il-33 Cytokines in Ulcerative Colitis, Autoimmunity Highlights (2019)
2. Immunoregulation of Inflammatory and Inhibitory Cytokines by Vitamin D3 in Patients With Inflammatory Bowel Diseases, Scandinavian Journal of Immunology (2017)
3. The Emerging Microbiome-Based Approaches to Ibd Therapy: From Scfas to Urolithin A, Journal of Digestive Diseases (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (6)
Elham Farhadi (3)
Other Related Docs
4. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms With Ulcerative Colitis and Crohn's Disease, Digestive Diseases (2018)
5. Role of Toll-Like Receptors in Inflammatory Bowel Disease, Pharmacological Research (2018)
6. Altered Microrna Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients, Immunological Investigations (2016)
7. Immunologic Balance of Regulatory T Cell/T Helper 17 Responses in Gastrointestinal Infectious Diseases: Role of Mirnas, Microbial Pathogenesis (2019)
8. Blood Regulatory T Cells in Inflammatory Bowel Disease, a Systematic Review, and Meta-Analysis, International Immunopharmacology (2023)
9. Modulation of Cytokine Expression by E. Coli Nissle 1917 and Its Omv in Intestinal Epithelial Cell Line Ht-29, Immunobiology (2025)
10. Possible Role of Intestinal Fungal Dysbiosis in Dectin-1 and Cytokines Expression in Patients With Ulcerative Colitis, Indian Journal of Gastroenterology (2024)
11. Analysis of Helios Gene Expression and Foxp3 Tsdr Methylation in the Newly Diagnosed Rheumatoid Arthritis Patients, Immunological Investigations (2018)
12. Buspirone Ameliorates Colon Inflammation in Tnbs-Induced Rat Acute Colitis: The Involvement of Tlr4/Nf-Kb Pathway, Drug Research (2022)
13. Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients With Inflammatory Bowel Disease, Immunological Investigations (2017)
14. Colonic Immune Cells in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis, Neurogastroenterology and Motility (2018)
15. Study the Effects of Mesenchymal Stem Cell Conditioned Medium Injection in Mouse Model of Acute Colitis, International Immunopharmacology (2018)
16. Early Onset Inflammatory Bowel Disease: Manifestations, Genetics and Diagnosis, Turkish Journal of Pediatrics (2019)
17. The Immune System and Autism Spectrum Disorder: Association and Therapeutic Challenges, Acta Neurobiologiae Experimentalis (2021)
18. Inflammatory Bowel Disease Therapies Discontinued Between 2009 and 2014, Expert Opinion on Investigational Drugs (2015)
19. An Evidence-Based Review of Medicinal Plants Cited in Canon of Medicine for Management of Inflammatory Bowel Disease, Medicinal Plants used in Traditional Persian Medicine (2023)
20. Upregulation of Unfolded Protein Response and Er Stress–Related Il-23 Production in M1 Macrophages From Ankylosing Spondylitis Patients, Inflammation (2022)